The 30-s chair stand test can be a useful tool for screening sarcopenia in elderly Japanese participants

Abstract Background Low muscle strength has been focused on as an essential characteristic of sarcopenia, and the 30-s chair stand test (CS-30) could be a particularly useful test for assessing muscle strength. While it is speculated to be a beneficial tool for the assessment of sarcopenia, this rem...

Full description

Saved in:
Bibliographic Details
Published inBMC musculoskeletal disorders Vol. 22; no. 1; pp. 1 - 639
Main Authors Sawada, Shuji, Ozaki, Hayao, Natsume, Toshiharu, Deng, Pengyu, Yoshihara, Toshinori, Nakagata, Takashi, Osawa, Takuya, Ishihara, Yoshihiko, Kitada, Tomoharu, Kimura, Ken, Sato, Nobuhiro, Machida, Shuichi, Naito, Hisashi
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 24.07.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Low muscle strength has been focused on as an essential characteristic of sarcopenia, and the 30-s chair stand test (CS-30) could be a particularly useful test for assessing muscle strength. While it is speculated to be a beneficial tool for the assessment of sarcopenia, this remains to be verified. In this study, we examined the reliability and optimal diagnostic score of the CS-30 for assessing sarcopenia in elderly Japanese participants. Methods This cross-sectional study included 678 participants (443 females and 235 males) who underwent the test for sarcopenia as per the Asian Working Group for Sarcopenia (AWGS) 2019, the CS-30 test, and the isometric knee-extension muscle strength test. ROC analysis was used to estimate the optimal CS-30 scores at which sarcopenia was detected. Results CS-30 scores were positively associated with sarcopenia (OR: 0.88; 95% CI:0.82–0.93). The AUC of the CS-30 for sarcopenia definition were 0.84 ( p  < 0.001) for females and 0.80 ( p  < 0.001) for males. The optimal number of stands in the CS-30 that predicted sarcopenia was 15 for females (sensitivity, 76.4%; specificity, 76.8%) and 17 for males (sensitivity, 75.0%; specificity, 71.7%). Conclusions The CS-30 was found to be a reliable test for sarcopenia screening in the elderly Japanese population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1471-2474
1471-2474
DOI:10.1186/s12891-021-04524-x